GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hyundai Pharmaceutical Co Ltd (XKRX:004310) » Definitions » Net Interest Income

Hyundai Pharmaceutical Co (XKRX:004310) Net Interest Income : ₩-1,264 Mil (TTM As of Feb. 2024)


View and export this data going back to 1978. Start your Free Trial

What is Hyundai Pharmaceutical Co Net Interest Income?

Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors. Hyundai Pharmaceutical Co's net interest income for the three months ended in Feb. 2024 was ₩-406 Mil. Its net interest income for the trailing twelve months (TTM) ended in Feb. 2024 was ₩-1,264 Mil.


Hyundai Pharmaceutical Co Net Interest Income Historical Data

The historical data trend for Hyundai Pharmaceutical Co's Net Interest Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hyundai Pharmaceutical Co Net Interest Income Chart

Hyundai Pharmaceutical Co Annual Data
Trend Nov14 Nov15 Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22 Nov23
Net Interest Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only -643.17 -567.23 -662.91 -767.91 -1,164.46

Hyundai Pharmaceutical Co Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Net Interest Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -202.17 -111.66 -361.02 -385.25 -405.78

Hyundai Pharmaceutical Co Net Interest Income Calculation

Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors.

Net Interest Income for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-1,264 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hyundai Pharmaceutical Co Net Interest Income Related Terms

Thank you for viewing the detailed overview of Hyundai Pharmaceutical Co's Net Interest Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Hyundai Pharmaceutical Co (XKRX:004310) Business Description

Traded in Other Exchanges
N/A
Address
Bonegeunsa Street 135, Hyundai Pharm Building, Gangnam-gu, Seoul, KOR, 135-545
Hyundai Pharmaceutical Co Ltd is a South Korea based company engage in the manufacturing and distribution of pharmaceutical products, health foods, and medical equipment.

Hyundai Pharmaceutical Co (XKRX:004310) Headlines

No Headlines